Harrow- 11.875% NT REDEEM 31/12/2027 USD 25 Long Term Debt

As of the most recent data (March 2026), HROWM shows a long-term debt of $300M. That compares with $120M in the prior-year period — up 147.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, HROWM's long-term debt is now $300M (was $120M) — a 147.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Harrow- 11.875% NT REDEEM 31/12/2027 USD 25 is outperforming or lagging.

Tracking HROWM's long-term debt over time shows whether Harrow- 11.875% NT REDEEM 31/12/2027 USD 25 is scaling, shrinking, or reshaping that part of the business. The current reading is $300M That compares with $120M in the prior-year period — up 147.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Harrow- 11.875% NT REDEEM 31/12/2027 USD 25's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $300M) with ownership activity and broader fundamentals.

Harrow- 11.875% NT REDEEM 31/12/2027 USD 25's long-term debt is $300M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.